Jalil, Angel Nadiyah D.

HRN: 20-79-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2023
CEFUROXIME 750MG (VIAL)
07/27/2023
08/03/2023
IV
300mg
Q8h
Pcap C
Waiting Final Action 
07/29/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/29/2023
08/04/2023
PO
1ml
Q6
Oral Ulcers
Waiting Final Action 
07/31/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
07/31/2023
08/04/2023
ORAL
5ml
BID
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: